查找临床试验
已按「年龄相关性黄斑变性」检索，对应国际通用词 age-related macular degeneration
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:24，每 5 分钟自动同步Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
China
年龄 18 Years – 80 Years
First Affiliated Hospital of Chongqing Medical University
Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
China
年龄 50 Years – 不限
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
United States、China、Czechia、Germany、Hungary 等 9 国
年龄 18 Years – 不限
Boehringer Ingelheim
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
United States、China
年龄 50 Years – 不限
Skyline Therapeutics
Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration
Hong Kong
年龄 50 Years – 不限
Hospital Authority, Hong Kong
Expressive Arts-based Intervention for Adults With Age-related Visual Impairment
Hong Kong
年龄 50 Years – 80 Years
The University of Hong Kong
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
China
年龄 50 Years – 85 Years
West China Hospital
Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
United States、Australia、China
年龄 18 Years – 65 Years
Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)
Direct Discrimination of Quantum States by the Human Eye
Hong Kong
年龄 18 Years – 不限
Centre for Eye and Vision Research
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
United States、China
年龄 50 Years – 不限
Skyline Therapeutics (US) Inc.
Learning Study: Improving Vision in Adults With Macular Degeneration
Canada、Hong Kong
年龄 18 Years – 不限
University of Waterloo
CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)
China
年龄 50 Years – 80 Years
HuidaGene Therapeutics Co., Ltd.